Journal
ONCOGENE
Volume 40, Issue 47, Pages 6494-6512Publisher
SPRINGERNATURE
DOI: 10.1038/s41388-021-02027-6
Keywords
-
Funding
- Projekt DEAL
Ask authors/readers for more resources
The sustained expression of IER2 drives melanoma invasion and progression through stimulating osteopontin secretion by inducing senescence in melanoma cells. Coordinate expression of IER2, p53/p21, and osteopontin in melanomas and metastases highlights the pathophysiological relevance of IER2-mediated senescence in melanoma progression.
Expression of the immediate-early response gene IER2 has been associated with the progression of several types of cancer, but its functional role is poorly understood. We found that increased IER2 expression in human melanoma is associated with shorter overall survival, and subsequently investigated the mechanisms through which IER2 exerts this effect. In experimental melanoma models, sustained expression of IER2 induced senescence in a subset of melanoma cells in a p53/MAPK/AKT-dependent manner. The senescent cells produced a characteristic secretome that included high levels of the extracellular phosphoglycoprotein osteopontin. Nuclear localization of the IER2 protein was critical for both the induction of senescence and osteopontin secretion. Osteopontin secreted by IER2-expressing senescent cells strongly stimulated the migration and invasion of non-senescent melanoma cells. Consistently, we observed coordinate expression of IER2, p53/p21, and osteopontin in primary human melanomas and metastases, highlighting the pathophysiological relevance of IER2-mediated senescence in melanoma progression. Together, our study reveals that sustained IER2 expression drives melanoma invasion and progression through stimulating osteopontin secretion via the stochastic induction of senescence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available